Fundraising Fox
/Companies
Sign in

Cellbricks

Berlin, DE · Founded 2016 · 6 known investors

Find your way into Cellbricks

Sign up to see every warm intro you have to Cellbricks

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cellbricks team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Cellbricks Therapeutics is a preclinical biotech company developing implantable tissue grafts using proprietary bioprinting technology, biomaterials, and human cells for regenerative medicine applications. The company combines deep tech innovation to restore tissue function at clinical scale across multiple therapeutic programs.

AI & Machine LearningBiotechDeep TechLongevity

Founders & leadership

Cellbricks was founded in 2016 by Alexander Leutner, Dr. Tobias Lam, and Alexander Thomas.

ALAlexander Leutner
Alexander LeutnerCo-CEO (Business) & Co-founderAlexander Leutner is Co-CEO and Co-founder of Cellbricks Therapeutics, a Berlin-based biotech company developing implantable tissue grafts using 3D-bioprinting technology for regenerative medicine. Previously, he co-founded Apodius in 2012, a metrology systems company spun out of RWTH Aachen University, which was later acquired by Hexagon AB; he holds a mechanical engineering degree from RWTH Aachen University.
DTDr. Tobias Lam
Dr. Tobias LamCTO & Co-founder
AT
Alexander ThomasSoft Tissue Program Lead & Co-founder
MK
Michael KringChief Financial Officer

Investors · 6

ACT Venture Partnerslisted by ACT Venture PartnersAmsterdam · $550K – $1.6M

How we know: press coverage · open dataset · 5k.vc investor directory · Not right? Tell us

Aurum Venture Partnerslisted by Aurum Venture PartnersPleasanton
Creative Destruction Lab (CDL)listed by Creative Destruction Lab (CDL)Toronto · $50K – $250K
Riceberg Ventures Premierlisted by Riceberg Ventures PremierAdliswil

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

VU Venture Partnerslisted by VU Venture PartnersSan Francisco · $200K – $1M

How we know: the VCSheet dataset · Not right? Tell us

Silicon Roundabout VenturesreportedSt. Albans

How we know: press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Cellbricks Therapeutics Secures $8. | SignalBasetrysignalbase.com · Mar 2026Cellbricks Therapeutics Raises €10M in Fundingfinsmes.com · Mar 2026Cellbricks Therapeutics Raises €10 Million New Capital to Move Living Tissue Implants Toward the Clinicglobenewswire.com · Mar 2026

Frequently asked questions

What does Cellbricks do?
Cellbricks Therapeutics is a preclinical biotech company developing implantable tissue grafts using proprietary bioprinting technology, biomaterials, and human cells for regenerative medicine applications. The company combines deep tech innovation to restore tissue function at clinical scale across multiple therapeutic programs.
Who founded Cellbricks?
Cellbricks was founded by Alexander Leutner, Dr. Tobias Lam, Alexander Thomas in 2016.
Who are Cellbricks's investors?
Cellbricks's investors include ACT Venture Partners, Aurum Venture Partners, Creative Destruction Lab (CDL), Riceberg Ventures Premier, VU Venture Partners, Silicon Roundabout Ventures.
Where is Cellbricks headquartered?
Cellbricks is headquartered in Berlin, DE.